Results 121 to 130 of about 2,785 (177)

Ulipristal acetate for emergency contraception

Drugs of Today, 2010
Ulipristal acetate is a progesterone receptor modulator. As an emergency contraceptive, a 30-mg micronized formulation is effective for use up to 120 h from unprotected sexual intercourse. Ulipristal acetate acts as an antagonist of the progesterone receptor at the transcriptional level and a competitive antagonist of glucocorticoid receptor function ...
J A, Russo, M D, Creinin
  +5 more sources

Ulipristal Acetate for Emergency Contraception

Annals of Pharmacotherapy, 2011
OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and safety of data of ulipristal acetate, a new emergency contraceptive approved for use up to 120 hours after unprotected intercourse. DATA SOURCES: Articles pertaining to the topic were identified and reviewed through searches of PubMed (1994-March 2011) and clinicaltrials.gov , using
Sara E, Snow   +2 more
openaire   +2 more sources

Ulipristal Acetate

Drugs, 2012
Ulipristal acetate, a selective progesterone-receptor modulator, inhibits the proliferation and induces apoptosis of leiomyoma cells in vitro. It also modulates the expression of vascular endothelial growth factors and hormone receptors and modulates extracellular matrix breakdown in leiomyoma cells but not in myometrial cells.
openaire   +2 more sources

Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis

Obstetrics & Gynecology, 2019
BACKGROUND: Disseminated peritoneal leiomyomatosis is a rare condition manifesting as hormone-sensitive soft tissue nodules lining the peritoneal cavity. Given the extensiveness of this disease, surgical management is challenging, making hormonal suppression the primary treatment. CASE:
Samantha, Benlolo   +2 more
openaire   +2 more sources

Ulipristal acetate: a new emergency contraceptive

Expert Review of Clinical Pharmacology, 2011
Ulipristal acetate (UPA) is a newly developed emergency contraceptive currently available in the USA and Europe. It is approved as a 30 mg one-time dose taken within 120 h (5 days) of unprotected intercourse or failed contraception. This selective progesterone receptor modulator appears to be more effective than the levonorgestrel-containing emergency ...
Jade L, Sullivan, Marilyn N, Bulloch
openaire   +2 more sources

Home - About - Disclaimer - Privacy